Wednesday, June 20, 2007

Compliance vs. Cost


The cost of medication for patients is often times the barrier between being compliant with physician recommendations. In an Archives of Internal Medicine Journal Sept. 2006, the survey found that 85% of patients are noncompliant with physician recommendations. Sixty seven percent are chronically ill and skip medications to save money and do not inform their physicians. Thirty five percent do not discuss their noncompliance and 32% were middle aged, noncompliant because of cost and noted their health to significantly decline in the past 2 years.

Physicians get on the average 5 phone calls daily from pharmacies about drugs being non-formulary and more than 18 calls daily for drugs that are not preferred. For our office, this means we have 20 calls for non-formulary changes and more than 90 for non-preferred drugs.

This is a huge burden to running an office and trying to treat the patients. Drugs are prescribed based on what we feel is best for the patient and not what is best for the insurance company’s formulary and bottom line.

The current system puts a huge strain on patients and physicians while the drug and insurance companies continue to make it ever more increasingly difficult. Some physicians are refusing to change prescriptions and places the complete burden back on the patient. Others try and compromise, but patients need to understand what their insurance covers and what it does not.

The insurance company doesn’t care about the patient if the required treatment falls outside of their coverage.

Labels: ,

7 Comments:

Anonymous Anonymous said...

HB, I am disappointed you didn't post something about last night's meeting and how the CEO tried to weasel out of giving any information about the audit.

You held him accountable and made him address the issue even though he passed the blame and still wouldn't reveal the results.

They must be bad.

So did the CEO lie about the Bond question you asked him? The management has been led to believe that the bond rating was up for reevaluation in June, but the CEO specifically stated no.

Do we believe what he said last night or what he has been saying since January?

6/20/2007 08:10:00 AM  
Anonymous Anonymous said...

It concerens me where the issue of presription medications is headed.The insurance comopanies want to pay for what is the least costly,which I understand,but this means that the newest and most innovative treatments will NOT be covered( except at patient expense). The system is set up to cover older medications and thus older technologies...nothing else in our economic system works this way. Most people prefer the "newest and best" of any product available.

6/20/2007 11:44:00 AM  
Anonymous Anonymous said...

most people prefer the "newest and best" possible

Would you prefer a Cadillac or a Chevy? Most people will answer "Cadillac".

Would you prefer a Cadillac which would cost you $60,000, or a Chevy which would cost $30,000? The answers then change.

6/20/2007 01:04:00 PM  
Anonymous Anonymous said...

Unfortunately, MANY things in our economic system are set up this way--especially where for-profit organizations (particularly healthcare) are concerned. Our mothers’ mothers’ mothers figured this out a few generations ago: An ounce of prevention is worth a pound of cure. Contemporary translation: You have to spend money now to keep from losing money later. But, try to tell that to the person holding the checkbook and he/she will look at you like you’re speaking in tongues.

6/20/2007 01:54:00 PM  
Anonymous Anonymous said...

It concerens me where the issue of presription medications is headed.The insurance comopanies want to pay for what is the least costly,which I understand,but this means that the newest and most innovative treatments will NOT be covered( except at patient expense). The system is set up to cover older medications and thus older technologies...nothing else in our economic system works this way. Most people prefer the "newest and best" of any product available.

Taking the latest and greatest prescription drug is not always in your best interest as you become a beta tester for the pharmaceutical companies. Post marketing drug studies have proven that some prescription medications have had dangerous side effect profiles that warranted removal from the market.

6/21/2007 07:23:00 AM  
Anonymous Anonymous said...

Not only do you become a "beta tester" as was last posted, you often are just being put on a medicine based on what a physician learned from the sales rep. Not saying that HB does that, just that I know physicians that do. Patients need to be informed and not follow treatment advice blindly.

6/25/2007 10:46:00 PM  
Anonymous Anonymous said...

Whatever. Where's your sense of adventure?

6/27/2007 12:26:00 PM  

Post a Comment

<< Home